SCEDULE 13G

Company

Larimar Therapeutics, Inc.

Filed

February 12, 2021

Accession Number

0000947871-21-000178

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →